Vault-13

Paradigm Biocapital Advisors LP

NEW YORK, NY · CIK 1855655 · 13F filing filed 2023-11-14

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$1.5bn reported value +18.6% vs Q2 2023
29positions
61.0%in top 10
6 new 19 added 3 reduced 6 sold out vs Q2 2023

Options: 2 call positions ($7.5m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 2,025,480 $136.1m9.28% 9.28% AddedShares held: Q4 2022 1.1m, Q1 2023 1.5m, Q2 2023 1.8m, Q3 2023 2.0m +219.8k +219,763 12.2%
2 ARGENX SE SPONSORED ADR ARGX ARGX 261,443 $128.5m8.77% 8.77% AddedShares held: Q4 2022 89.6k, Q1 2023 181.2k, Q2 2023 142.3k, Q3 2023 261.4k +119.2k +119,184 83.8%
3 ARCELLX INC COMMON STOCK ACLX ACLX 2,953,122 $106.0m7.23% 7.23% AddedShares held: Q4 2022 882.1k, Q1 2023 1.8m, Q2 2023 2.3m, Q3 2023 3.0m +606.1k +606,122 25.8%
4 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 7,803,600 $96.4m6.57% 6.57% AddedShares held: Q4 2022 0, Q1 2023 2.4m, Q2 2023 3.7m, Q3 2023 7.8m +4.1m +4,072,554 109.2%
5 NUVALENT INC COM COM 1,638,147 $75.3m5.14% 5.14% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 1.1m, Q3 2023 1.6m +517.7k +517,682 46.2%
6 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 3,642,307 $73.2m4.99% 4.99% AddedShares held: Q4 2022 1.2m, Q1 2023 1.8m, Q2 2023 2.0m, Q3 2023 3.6m +1.7m +1,656,877 83.5%
7 MIRATI THERAPEUTICS INC COM MRTX MRTX 1,668,116 $72.7m4.96% 4.96% AddedShares held: Q4 2022 1.3m, Q1 2023 1.4m, Q2 2023 1.4m, Q3 2023 1.7m +224.4k +224,354 15.5%
8 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 1,384,686 $71.9m4.90% 4.90% AddedShares held: Q4 2022 857.9k, Q1 2023 1.1m, Q2 2023 1.3m, Q3 2023 1.4m +114.6k +114,562 9.0%
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 307,314 $69.4m4.73% 4.73% AddedShares held: Q4 2022 148.9k, Q1 2023 211.9k, Q2 2023 238.4k, Q3 2023 307.3k +68.9k +68,926 28.9%
10 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 2,178,737 $64.8m4.42% 4.42% AddedShares held: Q4 2022 890.1k, Q1 2023 1.1m, Q2 2023 1.4m, Q3 2023 2.2m +783.7k +783,735 56.2%
11 DISC MEDICINE INC COM IRON IRON 1,272,279 $59.8m4.08% 4.08% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 1.3m
12 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,681,747 $56.5m3.85% 3.85% AddedShares held: Q4 2022 1.8m, Q1 2023 2.1m, Q2 2023 2.4m, Q3 2023 3.7m +1.3m +1,266,491 52.4%
13 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 2,532,972 $55.3m3.77% 3.77% AddedShares held: Q4 2022 0, Q1 2023 1.6m, Q2 2023 1.9m, Q3 2023 2.5m +664.0k +664,026 35.5%
14 INCYTE CORP COM INCY INCY 912,497 $52.7m3.60% 3.60% ReducedShares held: Q4 2022 852.8k, Q1 2023 1.3m, Q2 2023 1.4m, Q3 2023 912.5k -469.2k -469,214 -34.0%
15 XENON PHARMACEUTICALS INC COM XENE XENE 1,491,835 $51.0m3.48% 3.48% AddedShares held: Q4 2022 0, Q1 2023 651.1k, Q2 2023 989.3k, Q3 2023 1.5m +502.5k +502,508 50.8%
16 AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS 3,488,596 $40.1m2.74% 2.74% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 1.7m, Q3 2023 3.5m +1.8m +1,838,097 111.4%
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,390,077 $34.7m2.37% 2.37% ReducedShares held: Q4 2022 2.0m, Q1 2023 2.3m, Q2 2023 2.4m, Q3 2023 2.4m -34.1k -34,055 -1.4%
18 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 14,406,782 $33.6m2.29% 2.29% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 9.2m, Q3 2023 14.4m +5.2m +5,189,632 56.3%
19 TG THERAPEUTICS INC COM TGTX TGTX 3,619,015 $30.3m2.06% 2.06% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 3.6m
20 ZAI LAB LTD ADR ZLAB ZLAB 1,142,383 $27.8m1.89% 1.89% AddedShares held: Q4 2022 515.3k, Q1 2023 780.6k, Q2 2023 865.3k, Q3 2023 1.1m +277.1k +277,086 32.0%
21 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,421,743 $27.7m1.89% 1.89% ReducedShares held: Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.4m, Q3 2023 2.4m -2.2k -2,218 -0.1%
22 IMMATICS N.V SHS IMTX IMTX 2,058,447 $23.8m1.63% 1.63% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 2.0m, Q3 2023 2.1m +73.6k +73,634 3.7%
23 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 926,432 $15.1m1.03% 1.03% AddedShares held: Q4 2022 0, Q1 2023 962.4k, Q2 2023 893.9k, Q3 2023 926.4k +32.6k +32,571 3.6%
24 CARIBOU BIOSCIENCES INC COM CRBU CRBU 2,944,513 $14.1m0.96% 0.96% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 2.9m
25 VOR BIOPHARMA INC COM COM 6,461,467 $13.7m0.93% 0.93% UnchangedShares held: Q4 2022 6.4m, Q1 2023 6.5m, Q2 2023 6.5m, Q3 2023 6.5m
26 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,081,767 $12.6m0.86% 0.86% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 1.1m
27 KURA ONCOLOGY INC COM KURA KURA 1,212,828 $11.1m0.75% 0.75% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 1.0m, Q3 2023 1.2m +207.9k +207,920 20.7%
28 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 1,358,709 $10.1m0.69% 0.69% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 1.4m
29 COGENT BIOSCIENCES INC COM COGT COGT 225,605 $2.2m0.15% 0.15% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 225.6k

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
KARUNA THERAPEUTICS INC 283,605 $61.5m283.6k shares
BEIGENE LTD ONC ONC 216,093 $38.5m216.1k shares
VIR BIOTECHNOLOGY INC VIR VIR 1,014,239 $24.9m1.0m shares
MADRIGAL PHARMACEUTICALS INC MDGL MDGL 85,000 $19.6m85.0k shares
MOONLAKE IMMUNOTHERAPEUTICS MLTX MLTX 369,615 $18.9m369.6k shares
THESEUS PHARMACEUTICALS INC 1,950,327 $18.2m2.0m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
89BIO INC ETNB · Call ETNBCall 329,100 $5.1m329.1k shares New
AMBRX BIOPHARMA INC Call Call 209,600 $2.4m209.6k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
OLEMA PHARMACEUTICALS INC OLMA · 13G · filed 2025-02-14 OLMA 10.0%≈ $92.9m 13G 2025-02-14
EDGEWISE THERAPEUTICS INC EWTX · 13G · filed 2026-08-14 EWTX 9.5%≈ $415.1m +3.3 pts 13G 2026-08-14
ACHIEVE LIFE SCIENCES INC ACHV · 13G · filed 2026-04-24 ACHV 9.2%≈ $64.7m new 13G 2026-04-24
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-14 ASMB 7.8%≈ $42.7m +2.4 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 6.1%≈ $123.5m +1.0 pts 13G 2026-08-14
TYRA BIOSCIENCES INC TYRA · 13G · filed 2026-09-17 TYRA 5.8%≈ $110.9m new 13G 2026-09-17
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-08-14 LXEO 5.3%≈ $19.4m -3.0 pts 13G 2026-08-14
MBX BIOSCIENCES INC MBX · 13G · filed 2026-06-24 MBX 5.2%≈ $137.6m new 13G 2026-06-24
SPYRE THERAPEUTICS INC SYRE · 13G · filed 2026-10-01 SYRE 5.1%≈ $395.7m new 13G 2026-10-01
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-07-17 JBIO 5.1%≈ $69.0m new 13G 2026-07-17